Insights
From Explainable to Contestable AI: Lessons from Medical AI Ethics for Drug Discovery AI Drug Discovery
From Explainable to Contestable AI: Lessons from M...

By Julia Amann, Project Manager Strategy, Careum Foun...
From Generation to Discrimination: A New Lens on AI in Drug Discovery AI Drug Discovery
From Generation to Discrimination: A New Lens on A...

By Neil Kubica, Therapeutics Division Lead, General I...
AI-Enabled RNA Therapeutics and Metabolite-Depleting Aptamer Design AI Drug Discovery
AI-Enabled RNA Therapeutics and Metabolite-Depleti...

By Neil A. Bhowmick, Chief Scientific Officer, Kairos...
How AI Is Reshaping Biomarker Discovery in Drug Development AI Drug Discovery
How AI Is Reshaping Biomarker Discovery in Drug De...

By Polly Astill, Marketing Campaign Manager, Sygnatur...
How AI Is Changing Drug Discovery and What Still Stands in the Way AI Drug Discovery
How AI Is Changing Drug Discovery and What Still S...

By Daniel-Paul Bednarík, PhD, Chief Technology Office...
AI in Drug Discovery: It’s more than just complicated…it is complex AI Drug Discovery
AI in Drug Discovery: It’s more than just complica...

By Michael N. Liebman, PhD, Managing Director, IPQ An...
Beyond Search Rankings – AI Reshapes How Life Sciences Share Information Digital Transformation
Beyond Search Rankings – AI Reshapes How Life Scie...

By Haider Alleg, General Partner, Allegory Capital
Integrating Disaster Recovery into Business Continuity Management in alignment with ISO 22301 requirements with particular emphasis on real-world risk scenarios Digital Transformation
Integrating Disaster Recovery into Business Contin...

By Giulia Carna, Senior Data Protection Counsel, ACI...
Beyond the Chatbot: Why Life Sciences Research Digital Transformation
Beyond the Chatbot: Why Life Sciences Research

By David Cerf, Chief Data Evangelist, GRAU Data
Modernising Life Sciences: How Digital Transformation Is Redefining Safety, Scale and Sustainability Digital Transformation
Modernising Life Sciences: How Digital Transformat...

By Anupama Hatti, Head of Programme Delivery (Digital...
No Cost Surprises: How Transparent Clinical Trial Budget Builds Trust Between Sponsors and CROs CRO
No Cost Surprises: How Transparent Clinical Trial...

By Niranjan Andhalkar, Director- Strategic Management...
Revolutionizing Pharma Production with AI-Powered Solutions Pharma & Life Sciences
Revolutionizing Pharma Production with AI-Powered...

By Pavithran Ayyala, Head - Digital IT Services Busin...
Change Management in Healthcare Consolidation: Ensuring Research Continuity through CROs CRO
Change Management in Healthcare Consolidation: Ens...

By Dr. Peter Sandwall, Founder, CEO, Precision Physic...
Navigating Innovation and Complexity: Trends Shaping the Future of Veterinary CROs CRO
Navigating Innovation and Complexity: Trends Shapi...

By Poala Anfossi, General Manager, Vetspin
Why CROs Are Still Losing the Recruitment Battle – And What Comes Next CRO
Why CROs Are Still Losing the Recruitment Battle –...

By Rose Wang, Founder & CEO, 1104Health
The Changing CRO Environment: Responding to New Models of Service Delivery and Change CRO
The Changing CRO Environment: Responding to New Mo...

By Dr. Diana L. Foster, CEO, Total Diversity Clinical...

Latest News

Cencora Puts AI to Work to Improve Patient Access to Medicines
AI in Healthcare

Cencora Puts AI to Work to Improve...

By Editor Panel, Lifescience Outlook,...

AI Meets Drug Discovery as Italfarmaco and VeriSIM Life Target New Therapies
Drug Discovery

AI Meets Drug Discovery as Italfarm...

By Editor Panel, Lifescience Outlook,...

Eutecma and Tempaid Join Forces to Strengthen Global Cold Chain Packaging
Pharma & Life Sciences

Eutecma and Tempaid Join Forces to...

By Editor Panel, Lifescience Outlook,...

Oracle Brings AI and Connected Data to the Next Generation of Healthcare
AI in Healthcare

Oracle Brings AI and Connected Data...

By Editor Panel, Lifescience Outlook,...

AI Pushes Drug Discovery Toward a $13.8 Billion Future
Drug Discovery

AI Pushes Drug Discovery Toward a $...

By Editor Panel, Lifescience Outlook,...